™Grindr Agrees to Pay $250 Million to Bring HIV Prevention Into Its App
The West Hollywood dating app agreed to buy Freddie, a Canadian online PrEP provider expecting over $80 million in revenue this year.
Grindr wants to be where gay men get their HIV prevention pills, not just their dates. The West Hollywood dating app agreed on Sept. 30 to pay $250 million for PurposeMed, the Canadian parent of Freddie. Freddie is an online provider of PrEP, the daily medication that prevents HIV.
The bet starts with something users already put on their profiles. About 400,000 Grindr users in the U.S. list themselves as taking PrEP. The company figures more than 2 million others should be on it, it told shareholders in a letter filed with the Securities and Exchange Commission. Each one who signs up is worth real money. Grindr says a U.S. patient on Freddie's telehealth and pharmacy service brings in more than $400 a month.
Grindr hasn't done a deal like this before. The Los Angeles Business Journal reported that it's the company's first major acquisition since its founding in 2009. Grindr will pay roughly $190 million in cash and the other $60 million in its own shares, the filing says. The sellers could collect up to $70 million more in cash in 2028. That payout depends on the business hitting performance targets in 2027.
Both boards have signed off. The deal is expected to close in the fourth quarter of 2026, once the usual closing conditions are met.
What Grindr is buying is a working clinic without a waiting room. Physicians founded Freddie in Canada in 2020. It moved into the U.S. in 2024 and now treats patients in all 50 states and Washington, D.C. It employs and contracts its own clinicians and runs its own pharmacies that ship medication to patients. Its staff handle insurance, copays and reminders to stay on the drug. Freddie says it's served more than 55,000 patients since it started. It had more than 25,000 active ones at the end of September, by its own count.
It's also already profitable. Freddie expects more than $80 million in revenue this year, the filing says. It also expects more than $10 million in adjusted EBITDA, a common measure of operating profit.
“Grindr has a direct line to millions of gay men, and Freddie brings the medical expertise to turn that reach into care,” George Arison, who runs Grindr as CEO and also chairs its board, said in a statement the Business Journal published. The shareholder letter goes further. In it, he predicts health care could become a business as big as the dating app is today, and just as profitable.
For most patients, the drug itself shouldn't cost much. Under the Affordable Care Act, nearly every U.S. patient can get HIV prevention care with little or nothing out of pocket, the filing notes. Freddie works with community health clinics in a federal drug pricing program. The program lets them buy eligible medication at a discount and put the insurance payments toward care for patients who need help.
Grindr has tested this lane before. It launched Woodwork in 2025, an in-app health service selling erectile dysfunction pills, GLP-1 weight-loss drugs and peptide therapy, the Business Journal reported. The company's letter calls Woodwork a first step. Freddie becomes the base of a wider Grindr Health, the letter says. That starts with HIV and other STI care and, over time, moves toward longevity and general medicine. It also points to 2022, when more than 2 million gay men, by Grindr's count, turned to the app to find mpox vaccines.
The filing is plain about what could go wrong. Among the deal's risks, Grindr lists new privacy problems from folding Freddie's operations into the app. It also names guarding patient health records from hackers and complying with federal and state health privacy laws.
Grindr says it'll lay out the U.S. rollout and the app integration on its third-quarter earnings call in November. The letter already sketches the goal. Mock-up screens show a 90-day PrEP supply and the next lab test due, set beside the familiar profile of a man 786 feet away.
Source: labusinessjournal.com, retrieved October 5, 2026. Other sources: the SEC.
Comments 0